Identifier |
Name |
Gene |
Data |
Tissues |
Organism |
Actions |
DAA318 |
5'-3' exoribonuclease 1 |
ERI1 |
4.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA350 |
5'-nucleotidase, cytosolic II |
NT5C2 |
5.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA335 |
6-pyruvoyltetrahydropterin synthase |
PTS |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA1 |
abhydrolase domain containing 14A |
ABHD14A |
3.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2 |
abl-interactor 2 |
ABI2 |
18.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2061 |
acetyl-Coenzyme A carboxylase alpha increases with age |
ACACA |
63.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA383 |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
ANP32B |
4.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA3 |
actin, alpha 1, skeletal muscle |
ACTA1 |
16.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA393 |
actin, alpha, cardiac muscle 1 |
ACTC1 |
8.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA4 |
actin, beta |
ACTB |
4.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA538 |
actin binding LIM protein 1 |
ABLIM1 |
4.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA450 |
actin binding LIM protein family, member 2 |
ABLIM2 |
5.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA5 |
actin-like 6A |
ACTL6A |
21.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA542 |
actin related protein 2/3 complex, subunit 5-like |
ARPC5L |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2062 |
activin A receptor, type IB increases with age |
ACVR1B |
51.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA447 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
ADAMTS5 |
7.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA396 |
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 |
APPL1 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA12 |
adaptor-related protein complex 1, sigma 1 subunit |
AP1S1 |
12.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2132 |
adenylate kinase 3-like 2; adenylate kinase 3-like 1 increases with age |
AK4P3 |
54.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA2124 |
ADP-ribosylation-like factor 6 interacting protein 6 decreases with age |
ARL6IP6 |
76.1% DecreaseGene Expression Level |
ovary |
Human |
|
DAA551 |
AHA1, activator of heat shock 90kDa protein ATPase homolog 2 (yeast) |
AHSA2 |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA6 |
AHNAK nucleoprotein |
AHNAK |
13.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA474 |
A kinase (PRKA) anchor protein 7 |
AKAP7 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2431 |
aldehyde dehydrogenase 1A1 decreases with age |
ALDH1A1 |
30.3% DecreaseDNA Methylation |
dermis |
Human |
|
DAA7 |
aldehyde dehydrogenase 9 family, member A1 |
ALDH9A1 |
10.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA2428 |
aldo-keto reductase family 1; member C3 decreases with age |
AKR1C3 |
19.3% DecreaseDNA Methylation |
dermis |
Human |
|
DAA269 |
alpha-kinase 2 |
ALPK2 |
20.0% IncreaseGene Expression Level |
kidney |
Human |
|
DAA475 |
alpha-kinase 3 |
ALPK3 |
6.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA347 |
aminolevulinate, delta-, synthase 1 |
ALAS1 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2394 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
PRKAG3 |
17.8% DecreaseDNA Methylation |
dermis |
Human |
|
DAA2395 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
PRKAG3 |
20.1% DecreaseDNA Methylation |
dermis |
Human |
|
DAA2444 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
PRKAG3 |
20.1% DecreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2443 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
PRKAG3 |
15.1% DecreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA267 |
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
APBB1IP |
23.0% IncreaseGene Expression Level |
kidney |
Human |
|
DAA2100 |
anaphase promoting complex subunit 4 decreases with age |
ANAPC4 |
35.5% DecreaseGene Expression Level |
ovary |
Human |
|
DAA2119 |
angel homolog 2 (Drosophila) decreases with age |
ANGEL2 |
65.3% DecreaseGene Expression Level |
ovary |
Human |
|
DAA8 |
angiomotin |
AMOT |
10.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA9 |
ankyrin 2, neuronal |
ANK2 |
20.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA11 |
annexin A4 |
ANXA4 |
11.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA22 |
antizyme inhibitor 1 |
AZIN1 |
11.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA1223 |
APOE promoter methylation decrease |
APOE |
— |
prefrontal cortex |
Human |
|
DAA13 |
apolipoprotein D |
APOD |
14.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA373 |
apolipoprotein O |
APOO |
5.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2111 |
arginyl-tRNA synthetase 2, mitochondrial decreases with age |
RARS2 |
48.7% DecreaseGene Expression Level |
ovary |
Human |
|
DAA1202 |
arNOX specific activity increases |
ENOX1 |
— |
skin |
Human |
|
DAA306 |
arsA arsenite transporter, ATP-binding, homolog 1 (bacterial) |
ASNA1 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2088 |
aryl-hydrocarbon receptor repressor; programmed cell death 6 decreases with age |
PDCD6 |
60.9% DecreaseGene Expression Level |
ovary |
Human |
|
DAA14 |
arylsulfatase A |
ARSA |
17.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA2413 |
Arylsulfatase G increases with age |
ARSG |
19.6% IncreaseDNA Methylation |
dermis |
Human |
|
DAA2114 |
asparagine-linked glycosylation 13 homolog (S. cerevisiae) decreases with age |
ALG13 |
42.2% DecreaseGene Expression Level |
ovary |
Human
|
DAA498 |
ataxin 1 |
ATXN1 |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA359 |
AT hook containing transcription factor 1 |
AHCTF1 |
4.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA15 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
ATP2A2 |
9.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA16 |
ATPase, Ca++ transporting, plasma membrane 2 |
ATP2B2 |
23.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA21 |
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 |
ATP6V1G2 |
7.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA19 |
ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 |
ATP6V0D1 |
8.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA20 |
ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A |
ATP6V1A |
7.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2393 |
ATP-binding cassette; sub-family A member 8 decreases with age |
ABCA8 |
23.4% DecreaseDNA Methylation |
dermis |
Human |
|
DAA2442 |
ATP-binding cassette; sub-family A member 8 decreases with age |
ABCA8 |
25.0% DecreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA1091 |
ATP/GTP Binding Protein-like 5 |
AGBL5 |
IncreaseDNA Methylation |
pons |
Human |
|
DAA1090 |
ATP/GTP Binding Protein-like 5 |
AGBL5 |
IncreaseDNA Methylation |
frontal lobe |
Human |
|
DAA1089 |
ATP/GTP Binding Protein-like 5 |
AGBL5 |
IncreaseDNA Methylation |
cerebellum |
Human |
|
DAA1092 |
ATP/GTP Binding Protein-like 5 |
AGBL5 |
IncreaseDNA Methylation |
temporal lobe |
Human |
|
DAA421 |
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9) |
ATP5G1 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA530 |
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C3 (subunit 9) |
ATP5G3 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA17 |
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle |
ATP5A1 |
17.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA18 |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
ATP5B |
9.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA333 |
ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 |
ATP5C1 |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA327 |
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
ATP5O |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA299 |
ATP synthase mitochondrial F1 complex assembly factor 1 |
ATPAF1 |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2082 |
AT rich interactive domain 1A (SWI-like) increases with age |
ARID1A |
51.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA2083 |
AT rich interactive domain 1A (SWI-like) increases with age |
ARID1A |
103.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA24 |
B-cell CLL/lymphoma 11A (zinc finger protein) |
BCL11A |
14.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA509 |
BCL2-associated athanogene 2 |
BAG2 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA354 |
BCS1-like (yeast) |
BCS1L |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA23 |
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
B3GALNT1 |
22.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA1210 |
blood CRP level increase |
CRP |
— |
plasma |
Human |
|
DAA1211 |
blood HSP70 level increase |
— |
— |
plasma |
Human |
|
DAA477 |
bolA homolog 3 (E. coli) |
BOLA3 |
5.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA25 |
bone morphogenetic protein 7 |
BMP7 |
20.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA568 |
bone morphogenetic protein receptor, type IB |
BMPR1B |
11.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA289 |
brain protein 44-like |
BRP44L |
9.0% DecreaseGene Expression Level |
kidney |
Human |
|
DAA541 |
brain protein 44-like |
BRP44L |
5.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA453 |
butyrophilin-like 3 |
BTNL3 |
5.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA419 |
cadherin 5, type 2 (vascular endothelium) |
CDH5 |
6.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA33 |
calbindin 1, 28kDa |
CALB1 |
58.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA36 |
calcium/calmodulin-dependent protein kinase IV |
CAMK4 |
17.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA37 |
calcium/calmodulin-dependent protein kinase kinase 2, beta |
CAMKK2 |
7.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA32 |
calcium channel, voltage-dependent, beta 2 subunit |
CACNB2 |
8.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2461 |
calcyphosine isoform b decreases with age |
CAPS |
17.3% DecreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2412 |
calcyphosine isoform b decreases with age |
CAPS |
28.0% DecreaseDNA Methylation |
dermis |
Human |
|
DAA34 |
calmodulin 1 (phosphorylase kinase, delta) |
CALM1 |
5.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA35 |
calmodulin 3 (phosphorylase kinase, delta) |
CALM3 |
10.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA44 |
carbamoyl-phosphate synthetase 1, mitochondrial |
CPS1 |
20.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA443 |
carbonic anhydrase IV |
CA4 |
6.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA31 |
carbonic anhydrase XI |
CA11 |
6.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2401 |
casein kappa decreases with age |
CSN3 |
15.0% DecreaseDNA Methylation |
dermis |
Human |
|
DAA2450 |
casein kappa increases with age |
CSN3 |
16.3% IncreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2250 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
CASP1 |
165.5% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2248 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
CASP1 |
30.2% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2254 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
CASP1 |
91.8% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2261 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
CASP1 |
40.3% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2259 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
CASP1 |
42.0% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2255 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
CASP1 |
137.3% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2250 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
CASP1 |
165.5% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2253 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
CASP1 |
102.7% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2252 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
CASP1 |
101.8% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2248 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
CASP1 |
30.2% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2264 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
CASP1 |
53.3% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA346 |
CCAAT/enhancer binding protein (C/EBP), alpha |
CEBPA |
28.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA529 |
CCAAT/enhancer binding protein (C/EBP), beta |
CEBPB |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2221 |
CD14 molecule increases with age |
CD14 |
186.5% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2207 |
CD14 molecule increases with age |
CD14 |
395.0% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2236 |
CD14 molecule increases with age |
CD14 |
134.9% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2204 |
CD14 molecule increases with age |
CD14 |
154.3% IncreaseGene Expression Level |
temporal lobe |
Human |
|
DAA2272 |
CD163 molecule increases with age |
CD163 |
515.7% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2273 |
CD163 molecule increases with age |
CD163 |
552.3% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2288 |
CD163 molecule increases with age |
CD163 |
383.1% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2287 |
CD163 molecule increases with age |
CD163 |
283.0% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2280 |
CD163 molecule increases with age |
CD163 |
491.5% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2279 |
CD163 molecule increases with age |
CD163 |
488.1% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA469 |
CD207 molecule, langerin |
CD207 |
7.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2455 |
CD34 antigen isoform b decreases with age |
CD34 |
17.3% DecreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2406 |
CD34 antigen isoform b decreases with age |
CD34 |
16.6% DecreaseDNA Methylation |
dermis |
Human |
|
DAA45 |
Cdc2-related kinase, arginine/serine-rich |
CDK12 |
17.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA408 |
CDC42 effector protein (Rho GTPase binding) 3 |
CDC42EP3 |
6.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA462 |
CDK5 regulatory subunit associated protein 3 |
CDK5RAP3 |
4.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA95 |
cell division cycle 2-like 2 (PITSLRE proteins) |
CDC2L2 |
27.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA557 |
centromere protein V |
CENPV |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA349 |
centrosomal protein 350kDa |
CEP350 |
4.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2087 |
centrosomal protein 57kDa increases with age |
CEP57 |
86.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA2405 |
chemokine (C-C motif) receptor 1 decreases with age |
CCR1 |
16.5% DecreaseDNA Methylation |
dermis |
Human |
|
DAA2297 |
chemokine (C-C motif) receptor 1 increases with age |
CCR1 |
93.8% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2454 |
chemokine (C-C motif) receptor 1 increases with age |
CCR1 |
31.2% IncreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2303 |
chemokine (C-C motif) receptor 1 increases with age |
CCR1 |
53.9% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2302 |
Chemokine (C-C motif) receptor 1 increases with age |
CCR1 |
129.2% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2296 |
Chemokine (C-C motif) receptor 1 increases with age |
CCR1 |
182.5% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2295 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
CX3CL1 |
46.7% DecreaseGene Expression Level |
temporal lobe |
Human |
|
DAA2308 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
CX3CL1 |
58.0% DecreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2298 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
CX3CL1 |
31.6% DecreaseGene Expression Level |
hippocampus |
Human |
|
DAA2307 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
CX3CL1 |
61.1% DecreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2305 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
CX3CL1 |
56.2% DecreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2304 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
CX3CL1 |
61.0% DecreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2300 |
chemokine (C-X-C motif) ligand 12 decreases with age |
CXCL12 |
30.9% DecreaseGene Expression Level |
hippocampus |
Human |
|
DAA2309 |
chemokine (C-X-C motif) ligand 16 increases with age |
CXCL16 |
44.1% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2306 |
chemokine (C-X-C motif) ligand 16 increases with age |
CXCL16 |
78.9% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2301 |
chemokine (C-X-C motif) ligand 16 increases with age |
CXCL16 |
100.6% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2299 |
chemokine (C-X-C motif) ligand 5 increases with age |
CXCL5 |
64.9% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA305 |
chemokine-like factor |
CKLF |
4.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA43 |
chimerin (chimaerin) 1 |
CHN1 |
6.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA39 |
cholecystokinin |
CCK |
6.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA40 |
cholecystokinin B receptor |
CCKBR |
11.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA448 |
chromatin modifying protein 2A |
CHMP2A |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA364 |
chromobox homolog 7 |
CBX7 |
4.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA478 |
chromosome 11 open reading frame 73 |
C11orf73 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2110 |
chromosome 12 open reading frame 35 increases with age |
KIAA1551 |
71.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA2390 |
chromosome 14 open reading frame 177 decreases with age |
C14orf177 |
16.2% DecreaseDNA Methylation |
dermis |
Human |
|
DAA309 |
chromosome 14 open reading frame 2 |
C14orf2 |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA504 |
chromosome 16 open reading frame 61 |
C16orf61 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA342 |
chromosome 18 open reading frame 19 |
C18orf19 |
5.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA291 |
chromosome 1 open reading frame 162 |
C1orf162 |
37.0% IncreaseGene Expression Level |
kidney |
Human |
|
DAA27 |
chromosome 1 open reading frame 95 |
C1orf95 |
5.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA385 |
chromosome 2 open reading frame 88 |
C2orf88 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA480 |
chromosome 4 open reading frame 17 |
C4orf17 |
13.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2126 |
chromosome 4 open reading frame 34 decreases with age |
SMIM14 |
35.9% DecreaseGene Expression Level |
ovary |
Human |
|
DAA28 |
chromosome 5 open reading frame 13 |
C5orf13 |
8.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA124 |
chromosome 5 open reading frame 30 |
C5orf30 |
19.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA29 |
chromosome 6 open reading frame 106 |
C6orf106 |
12.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA358 |
chromosome 6 open reading frame 136 |
C6orf136 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA404 |
chromosome 7 open reading frame 44 |
C7orf44 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA506 |
chromosome 9 open reading frame 123 |
C9orf123 |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA552 |
chromosome X open reading frame 57 |
CXorf57 |
35.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2055 |
Circulating miR-21 expression increases |
— |
— |
blood |
Human |
|
DAA426 |
citrate lyase beta like |
CLYBL |
6.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA263 |
claudin 8 |
CLDN8 |
17.0% DecreaseGene Expression Level |
kidney |
Human |
|
DAA2168 |
Clusterin increases with age |
CLU |
25.9% IncreaseGene Expression Level |
temporal lobe |
Human |
|
DAA2193 |
Clusterin increases with age |
CLU |
47.9% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2178 |
Clusterin increases with age |
CLU |
33.1% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2201 |
Clusterin increases with age |
CLU |
25.5% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2203 |
Clusterin increases with age |
CLU |
56.5% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2202 |
Clusterin increases with age |
CLU |
30.9% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2192 |
Clusterin increases with age |
CLU |
23.5% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2191 |
Clusterin increases with age |
CLU |
22.5% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2180 |
Clusterin increases with age |
CLU |
58.9% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2179 |
Clusterin increases with age |
CLU |
41.7% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA379 |
coenzyme Q9 homolog (S. cerevisiae) |
COQ9 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA281 |
coiled-coil domain containing 3 |
CCDC3 |
19.0% IncreaseGene Expression Level |
kidney |
Human |
|
DAA138 |
coiled-coil domain containing 46 |
CCDC46 |
86.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA507 |
coiled-coil domain containing 72 |
CCDC72 |
2.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA435 |
coiled-coil-helix-coiled-coil-helix domain containing 10 |
CHCHD10 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA501 |
coiled-coil-helix-coiled-coil-helix domain containing 3 |
CHCHD3 |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA442 |
cold inducible RNA binding protein |
CIRBP |
2.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA46 |
collapsin response mediator protein 1 |
CRMP1 |
4.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA49 |
colony stimulating factor 2 (granulocyte-macrophage) |
CSF2 |
6.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA2181 |
complement component 1, q subcomponent, A chain increases with age |
C1QA |
154.9% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2169 |
complement component 1, q subcomponent, A chain increases with age |
C1QA |
243.4% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2194 |
complement component 1, q subcomponent, A chain increases with age |
C1QA |
98.4% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2182 |
complement component 1, q subcomponent, B chain increases with age |
C1QB |
288.1% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2170 |
complement component 1, q subcomponent, B chain increases with age |
C1QB |
391.4% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2166 |
complement component 1, q subcomponent, B chain increases with age |
C1QB |
186.7% IncreaseGene Expression Level |
temporal lobe |
DAA2195 |
complement component 1, q subcomponent, B chain increases with age |
C1QB |
166.8% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA275 |
complement component 1, q subcomponent, C chain |
C1QC |
27.0% IncreaseGene Expression Level |
kidney |
Human |
|
DAA2171 |
complement component 1, q subcomponent, C chain increases with age |
C1QC |
323.4% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2167 |
complement component 1, q subcomponent, C chain increases with age |
C1QC |
154.3% IncreaseGene Expression Level |
temporal lobe |
Human |
|
DAA2196 |
complement component 1, q subcomponent, C chain increases with age |
C1QC |
126.1% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2183 |
complement component 1, q subcomponent, C chain increases with age |
C1QC |
216.2% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA520 |
complement component 1, r subcomponent |
C1R |
8.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA288 |
complement component 1, r subcomponent |
C1R |
21.0% IncreaseGene Expression Level |
kidney |
Human |
|
DAA367 |
complement component 1, s subcomponent |
C1S |
7.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA265 |
complement component 1, s subcomponent |
C1S |
24.0% IncreaseGene Expression Level |
kidney |
Human |
|
DAA2172 |
complement component 1, s subcomponent increases with age |
C1S |
152.9% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2197 |
complement component 1, s subcomponent increases with age |
C1S |
71.9% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2185 |
complement component 1, s subcomponent increases with age |
C1S |
60.4% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2173 |
complement component 1, s subcomponent increases with age |
C1S |
105.3% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2184 |
complement component 1, s subcomponent increases with age |
C1S |
54.0% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA487 |
complement component 3 |
C3 |
16.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2198 |
complement component 3a receptor 1 increases with age |
C3AR1 |
89.0% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2187 |
complement component 3a receptor 1 increases with age |
C3AR1 |
134.8% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2175 |
complement component 3a receptor 1 increases with age |
C3AR1 |
197.0% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2186 |
complement component 3 increases with age |
C3 |
108.4% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2174 |
complement component 3 increases with age |
C3 |
201.6% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2151 |
complement component 4A increases with age |
C4A |
153.8% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2149 |
complement component 4A increases with age |
C4A |
216.4% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2148 |
complement component 4A increases with age |
C4A |
226.3% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2146 |
complement component 4A increases with age |
C4A |
115.3% IncreaseGene Expression Level |
temporal lobe |
Human |
|
DAA2153 |
complement component 4A increases with age |
C4A |
187.3% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2152 |
complement component 4B increases with age |
C4B |
444.8% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2147 |
complement component 4B increases with age |
C4B |
289.9% IncreaseGene Expression Level |
temporal lobe |
Human |
|
DAA2154 |
complement component 4B increases with age |
C4B |
895.9% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2150 |
complement component 4B increases with age |
C4B |
466.1% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2176 |
complement component 5a receptor 1 increases with age |
C5AR1 |
166.2% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2189 |
complement component 5a receptor 1 increases with age |
C5AR1 |
34.3% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2199 |
complement component 5 increases with age |
C5 |
43.7% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2188 |
complement component 5 increases with age |
C5 |
35.3% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2392 |
complement factor D preproprotein decreases with age |
CFD |
21.7% DecreaseDNA Methylation |
dermis |
Human |
|
DAA2441 |
complement factor D preproprotein increases with age |
CFD |
22.2% IncreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2177 |
complement factor H increases with age |
CFH |
166.8% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2200 |
complement factor H increases with age |
CFH |
210.8% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2190 |
complement factor H increases with age |
CFH |
138.9% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA42 |
complement factor H-related 1 |
CFHR1 |
42.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA2159 |
complement factor H-related 1 increases with age |
CFHR1 |
144.2% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2158 |
complement factor H-related 1 increases with age |
CFHR1 |
126.5% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2157 |
complement factor H-related 1 increases with age |
CFHR1 |
88.0% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2038 |
Concentration of cell free DNA increases |
— |
— |
plasma |
Human |
|
DAA287 |
creatine kinase, brain |
CKB |
10.0% DecreaseGene Expression Level |
kidney |
Human |
|
DAA470 |
creatine kinase, mitochondrial 2 (sarcomeric) |
CKMT2 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2047 |
creatinine levels increase |
— |
— |
plasma |
Human |
|
DAA47 |
crystallin, beta B3 |
CRYBB3 |
4.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA48 |
crystallin, mu |
CRYM |
12.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA316 |
CTAGE family, member 4 |
CTAGE4 |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2424 |
C-type lectin domain family 3; member B decreases with age |
CLEC3B |
18.0% DecreaseDNA Methylation |
dermis |
Human |
|
DAA51 |
cut-like homeobox 2 |
CUX2 |
19.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA41 |
cyclin-dependent kinase 5 |
CDK5 |
7.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2423 |
cyclin-dependent kinase 5; regulatory subunit 1 decreases with age |
CDK5R1 |
17.2% DecreaseDNA Methylation |
dermis |
Human |
|
DAA444 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
CDKN1A |
50.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2063 |
cyclin-dependent kinase inhibitor 1C (p57, Kip2) decreases with age |
CDKN1C |
69.3% DecreaseGene Expression Level |
ovary |
Human |
|
DAA2433 |
cyclin-dependent kinase inhibitor 2B isoform 2 decreases with age |
CDKN2B |
16.7% DecreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2384 |
cyclin-dependent kinase inhibitor 2B isoform 2 increases with age |
CDKN2B |
26.0% IncreaseDNA Methylation |
dermis |
Human |
|
DAA1072 |
CYFIP2 A to I mRNA editing decreases |
CYFIP2 |
IncreasemRNA Editing |
frontal lobe |
Human |
|
DAA38 |
cystathionine-beta-synthase |
CBS |
18.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA403 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
CRIM1 |
6.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA570 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
CRIM1 |
9.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA482 |
cytochrome c-1 |
CYC1 |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA415 |
cytochrome c oxidase subunit IV isoform 1 |
COX4I1 |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA569 |
cytochrome c oxidase subunit VIIb |
COX7B |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA329 |
cytochrome c, somatic |
CYCS |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA52 |
cytochrome P450, family 2, subfamily J, polypeptide 2 |
CYP2J2 |
9.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA489 |
cytochrome P450, family 4, subfamily X, polypeptide 1 |
CYP4X1 |
12.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA273 |
cytoplasmic FMR1 interacting protein 2 |
CYFIP2 |
11.0% DecreaseGene Expression Level |
kidney |
Human |
|
DAA572 |
D-dopachrome tautomerase |
DDT |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA56 |
DEAD (Asp-Glu-Ala-As) box polypeptide 19B |
DDX19B |
9.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA293 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 24 |
DDX24 |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA57 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39 |
DDX39 |
8.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA382 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 42 |
DDX42 |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA406 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 59 |
DDX59 |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA1231 |
decreased NF-KappaB induction in T cells |
— |
— |
T cell |
Human |
|
DAA1232 |
decreased proteasomal activity in T cells |
— |
— |
T cell |
Human |
|
DAA272 |
dedicator of cytokinesis 11 |
DOCK11 |
24.0% IncreaseGene Expression Level |
kidney |
Human |
|
DAA256 |
defensin, beta 1 |
DEFB1 |
8.0% DecreaseGene Expression Level |
kidney |
Human |
|
DAA2437 |
dehydrogenase/reductase (SDR family) member 3 decreases with age |
DHRS3 |
18.6% DecreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2388 |
dehydrogenase/reductase (SDR family) member 3 decreases with age |
DHRS3 |
15.8% DecreaseDNA Methylation |
dermis |
Human |
|
DAA54 |
dendrin |
DDN |
9.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA122 |
destrin-2 pseudogene |
|
15.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA58 |
diacylglycerol kinase, beta 90kDa |
DGKB |
7.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2419 |
dickkopf homolog 1 precursor increases with age |
DKK1 |
16.2% IncreaseDNA Methylation |
dermis |
Human |
|
DAA1111 |
Dickkopf-like 1 |
DKKL1 |
IncreaseDNA Methylation |
pons |
Human |
|
DAA1110 |
Dickkopf-like 1 |
DKKL1 |
IncreaseDNA Methylation |
frontal lobe |
Human |
|
DAA1109 |
Dickkopf-like 1 |
DKKL1 |
IncreaseDNA Methylation |
cerebellum |
Human |
|
DAA1112 |
Dickkopf-like 1 |
DKKL1 |
IncreaseDNA Methylation |
temporal lobe |
Human |
|
DAA368 |
dihydrolipoamide S-acetyltransferase |
DLAT |
6.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA64 |
dihydropyrimidinase-like 3 |
DPYSL3 |
12.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA1083 |
Dipeptidyl-peptidase 8 |
DPP8 |
IncreaseDNA Methylation |
pons |
Human |
|
DAA1081 |
Dipeptidyl-peptidase 8 |
DPP8 |
IncreaseDNA Methylation |
cerebellum |
Human |
|
DAA1082 |
Dipeptidyl-peptidase 8 |
DPP8 |
IncreaseDNA Methylation |
frontal lobe |
Human |
|
DAA1084 |
Dipeptidyl-peptidase 8 |
DPP8 |
IncreaseDNA Methylation |
temporal lobe |
Human |
|
DAA55 |
discoidin domain receptor tyrosine kinase 1 |
DDR1 |
9.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA61 |
discs, large (Drosophila) homolog-associated protein 1 |
DLGAP1 |
11.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA300 |
discs, large homolog 5 (Drosophila) |
DLG5 |
4.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA503 |
dishevelled associated activator of morphogenesis 2 |
DAAM2 |
5.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA571 |
dishevelled associated activator of morphogenesis 2 |
DAAM2 |
8.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA1997 |
DNA damage increases with age |
— |
— |
skin |
Human |
|
DAA62 |
DnaJ (Hsp40) homolog, subfamily A, member 1 |
DNAJA1 |
9.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA545 |
DnaJ (Hsp40) homolog, subfamily C, member 1 |
DNAJC1 |
5.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA460 |
DnaJ (Hsp40) homolog, subfamily C, member 15 |
DNAJC15 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA577 |
dopey family member 1 |
DOPEY1 |
9.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA546 |
doublesex and mab-3 related transcription factor 2 |
DMRT2 |
12.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA445 |
DPH5 homolog (S. cerevisiae) |
DPH5 |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA490 |
dual specificity phosphatase 13 |
DUSP13 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA65 |
dual specificity phosphatase 3 |
DUSP3 |
6.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA521 |
dual specificity phosphatase 3 |
DUSP3 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA53 |
dynactin 1 (p150, glued homolog, Drosophila) |
DCTN1 |
9.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA63 |
dynamin 1-like |
DNM1L |
14.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA377 |
dystrophin |
DMD |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2066 |
E1A binding protein p300 decreases with age |
EP300 |
69.2% DecreaseGene Expression Level |
ovary |
Human |
|
DAA2064 |
echinoderm microtubule associated protein like 1 decreases with age |
EML1 |
87.8% DecreaseGene Expression Level |
ovary |
Human |
|
DAA567 |
ECSIT homolog (Drosophila) |
ECSIT |
5.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA75 |
ectodermal-neural cortex (with BTB-like domain) |
ENC1 |
5.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA1065 |
efflux pump activity decreases |
— |
— |
blood brain barrier |
Human |
|
DAA500 |
EF-hand calcium binding domain 7 |
EFCAB7 |
12.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA258 |
EF-hand domain family, member D1 |
EFHD1 |
9.0% DecreaseGene Expression Level |
kidney |
Human |
|
DAA68 |
EGF-containing fibulin-like extracellular matrix protein 1 |
EFEMP1 |
34.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA69 |
EGF-containing fibulin-like extracellular matrix protein 2 |
EFEMP2 |
10.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA548 |
EGF-containing fibulin-like extracellular matrix protein 2 |
EFEMP2 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA71 |
EH-domain containing 1 |
EHD1 |
4.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA73 |
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R) |
ELAVL1 |
69.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA74 |
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) |
ELAVL2 |
10.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2108 |
elongation protein 3 homolog (S. cerevisiae) decreases with age |
ELP3 |
54.1% DecreaseGene Expression Level |
ovary |
Human |
|
DAA2065 |
empty spiracles homeobox 1 increases with age |
EMX1 |
80.0% IncreaseGene Expression Level |
ovary |
Human |
|
DAA479 |
endomucin |
EMCN |
6.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA77 |
endosulfine alpha |
ENSA |
9.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2415 |
engrailed homolog 1 increases with age |
EN1 |
18.8% IncreaseDNA Methylation |
dermis |
Human |
|
DAA76 |
enolase 3 (beta, muscle) |
ENO3 |
38.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA271 |
epidermal growth factor (beta-urogastrone) |
EGF |
25.0% DecreaseGene Expression Level |
kidney |
Human |
|
DAA2067 |
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) decreases with age |
EPB41 |
42.2% DecreaseGene Expression Level |
ovary |
Human |
|
DAA362 |
erythrocyte membrane protein band 4.1-like 2 |
EPB41L2 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA573 |
estrogen receptor 2 (ER beta) |
ESR2 |
5.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA376 |
estrogen-related receptor alpha |
ESRRA |
5.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA72 |
eukaryotic translation initiation factor 4A, isoform 2 |
EIF4A2 |
3.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA532 |
eukaryotic translation initiation factor 4H |
EIF4H |
2.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA564 |
exosome component 10 |
EXOSC10 |
7.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA554 |
exportin 6 |
XPO6 |
3.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA982 |
expression of CD16 receptor diminished |
FCGR3A |
— |
neutrophil |
Human |
|
DAA2034 |
Expression of WRN decreases |
WRN |
52.0% DecreaseGene Expression Level |
blood, immune system |
Human |
|
DAA66 |
extracellular matrix protein 2, female organ and adipocyte specific |
ECM2 |
13.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA137 |
family with sequence similarity 131, member A |
FAM131A |
10.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA304 |
family with sequence similarity 162, member A |
FAM162A |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA558 |
family with sequence similarity 174, member B |
FAM174B |
9.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2134 |
family with sequence similarity 33, member A; similar to Spindle and kinetochore-associated protein 2 decreases with age |
SKA2P1 |
36.7% DecreaseGene Expression Level |
ovary |
Human |
|
DAA80 |
family with sequence similarity 49, member A |
FAM49A |
16.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA434 |
family with sequence similarity 96, member A |
FAM96A |
4.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA374 |
Fas-activated serine/threonine kinase |
FASTK |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA574 |
fasciculation and elongation protein zeta 2 (zygin II) |
FEZ2 |
5.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA78 |
fatty acid desaturase 1 |
FADS1 |
7.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA2123 |
F-box and leucine-rich repeat protein 16 decreases with age |
FBXL16 |
51.7% DecreaseGene Expression Level |
ovary |
Human |
|
DAA308 |
F-box and WD repeat domain containing 12 |
FBXW12 |
9.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA427 |
F-box protein 31 |
FBXO31 |
7.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA2269 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
FCER1G |
144.2% IncreaseGene Expression Level |
temporal lobe |
Human |
|
DAA2281 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
FCER1G |
187.2% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2289 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
FCER1G |
105.3% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2274 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
FCER1G |
342.8% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2270 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
FCER1G |
98.1% IncreaseGene Expression Level |
temporal lobe |
Human |
|
DAA2290 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
FCER1G |
111.4% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2282 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
FCER1G |
177.4% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2275 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
FCER1G |
222.6% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2276 |
Fc fragment of IgG binding protein increases with age |
FCGBP |
138.3% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2283 |
Fc fragment of IgG binding protein increases with age |
FCGBP |
290.6% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2291 |
Fc fragment of IgG binding protein increases with age |
FCGBP |
212.4% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2138 |
Fc fragment of IgG, high affinity Ia, receptor (CD64) increases with age |
FCGR1A |
151.0% IncreaseGene Expression Level |
temporal lobe |
Human |
|
DAA2140 |
Fc fragment of IgG, high affinity Ia, receptor (CD64) increases with age |
FCGR1A |
423.1% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2144 |
Fc fragment of IgG, high affinity Ia, receptor (CD64) increases with age |
FCGR1A |
157.3% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2142 |
Fc fragment of IgG, high affinity Ia, receptor (CD64) increases with age |
FCGR1A |
207.6% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2145 |
Fc fragment of IgG, high affinity Ib, receptor (CD64) increases with age |
FCGR1B |
170.4% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2143 |
Fc fragment of IgG, high affinity Ib, receptor (CD64) increases with age |
FCGR1B |
225.5% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2141 |
Fc fragment of IgG, high affinity Ib, receptor (CD64) increases with age |
FCGR1B |
434.2% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2139 |
Fc fragment of IgG, high affinity Ib, receptor (CD64) increases with age |
FCGR1B |
166.0% IncreaseGene Expression Level |
temporal lobe |
Human |
|
DAA2292 |
Fc fragment of IgG, low affinity IIa, receptor (CD32) increases with age |
FCGR2A |
104.3% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2284 |
Fc fragment of IgG, low affinity IIa, receptor (CD32) increases with age |
FCGR2A |
141.5% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2277 |
Fc fragment of IgG, low affinity IIa, receptor (CD32) increases with age |
FCGR2A |
316.4% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2271 |
Fc fragment of IgG, low affinity IIa, receptor (CD32) increases with age |
FCGR2A |
124.0% IncreaseGene Expression Level |
temporal lobe |
Human |
|
DAA2293 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
FCGR3B |
52.1% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2285 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
FCGR3B |
131.1% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2278 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
FCGR3B |
80.8% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2161 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
FCGR3B |
404.6% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2162 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
FCGR3B |
261.1% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA2160 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
FCGR3B |
647.0% IncreaseGene Expression Level |
hippocampus |
Human |
|
DAA2286 |
Fc fragment of IgG, receptor, transporter, alpha increases with age |
FCGRT |
76.7% IncreaseGene Expression Level |
parietal lobe |
Human |
|
DAA2294 |
Fc fragment of IgG, receptor, transporter, alpha increases with age |
FCGRT |
89.3% IncreaseGene Expression Level |
frontal lobe |
Human |
|
DAA171 |
FERM and PDZ domain containing 4 |
FRMPD4 |
22.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA356 |
FERM domain containing 3 |
FRMD3 |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA553 |
ferredoxin 1 |
FDX1 |
6.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA82 |
fibroblast growth factor 12 |
FGF12 |
29.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA83 |
fibroblast growth factor 13 |
FGF13 |
28.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA81 |
fibroblast growth factor 1 (acidic) |
FGF1 |
20.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA84 |
fibroblast growth factor 2 (basic) |
FGF2 |
12.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA85 |
fibroblast growth factor receptor 3 |
FGFR3 |
13.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA303 |
FK506 binding protein 1A, 12kDa |
FKBP1A |
3.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA536 |
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor recep |
FLT1 |
6.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA544 |
follistatin |
FST |
8.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA535 |
forkhead box O1 |
FOXO1 |
6.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA488 |
fumarate hydratase |
FH |
2.0% DecreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA79 |
fumarylacetoacetate hydrolase (fumarylacetoacetase) |
FAH |
10.0% IncreaseGene Expression Level |
brain |
Human |
|
DAA280 |
FXYD domain containing ion transport regulator 2 |
FXYD2 |
5.0% DecreaseGene Expression Level |
kidney |
Human |
|
DAA310 |
gametogenetin binding protein 2 |
GGNBP2 |
5.0% IncreaseGene Expression Level |
skeletal muscle |
Human |
|
DAA87 |
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
GABRB3 |
31.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA88 |
gamma-aminobutyric acid (GABA) A receptor, delta |
GABRD |
9.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA90 |
GDNF family receptor alpha 2 |
GFRA2 |
6.0% DecreaseGene Expression Level |
brain |
Human |
|
DAA2460 |
gelsolin-like capping protein decreases with age |
CAPG |
19.3% DecreaseDNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2411 |
gelsolin-like capping protein decreases with age |
CAPG |
20.1% DecreaseDNA Methylation |
dermis |
Human |
|
DAA4096 |
Gene expression of AACS decreases with age |
AACS |
— |
skin |
Human |
|
DAA2965 |
Gene expression of AADAC decreases with age |
AADAC |
— |
skin |
Human |
|
DAA2966 |
Gene expression of ABCA1 increases with age |
ABCA1 |
— |
skin |
Human |
|
DAA2967 |
Gene expression of ABCA4 decreases with age |
ABCA4 |
— |
skin |
Human |
|
DAA3728 |
Gene expression of ABCA5 increases with age |
ABCA5 |
— |
skin |
Human |
|
DAA3320 |
Gene expression of ABCB1 increases with age |
ABCB1 |
— |
skin |
Human |
|
DAA3607 |
Gene expression of ABCC4 decreases with age |
ABCC4 |
— |
skin |
Human |
|
DAA4344 |
Gene expression of ABHD12B decreases with age |
ABHD12B |
— |
skin |
Human |
|
DAA3777 |
Gene expression of ABHD12 decreases with age |
ABHD12 |
— |
skin |
Human |
|
DAA3760 |
Gene expression of ABHD14A decreases with age |
ABHD14A |
— |
skin |
Human |
|
DAA3836 |
Gene expression of ABHD5 decreases with age |
ABHD5 |
— |
skin |
Human |
|
DAA3762 |
Gene expression of ABI3BP decreases with age |
ABI3BP |
— |
skin |
Human |
|
DAA2777 |
Gene expression of ACACA decreases with age |
ACACA |
— |
adipose tissue |
Human |
|
DAA2968 |
Gene expression of ACACA decreases with age |
ACACA |
— |
skin |
Human |
|
DAA4158 |
Gene expression of ACAD10 increases with age |
ACAD10 |
— |
skin |
Human |
|
DAA4188 |
Gene expression of ACAD11 increases with age |
ACAD11 |
— |
skin |
Human |
|
DAA3791 |
Gene expression of ACAD8 decreases with age |
ACAD8 |
— |
skin |
Human |
DAA2969 |
Gene expression of ACADL increases with age |
ACADL |
— |
skin |
Human |
|
DAA2970 |
Gene expression of ACADM decreases with age |
ACADM |
— |
skin |
Human |
|
DAA2778 |
Gene expression of ACADVL decreases with age |
ACADVL |
— |
adipose tissue |
Human |
|
DAA2971 |
Gene expression of ACAT2 decreases with age |
ACAT2 |
— |
skin |
Human |
|
DAA2914 |
Gene expression of ACE2 increases with age |
ACE2 |
— |
adipose tissue |
Human |
|
DAA2904 |
Gene expression of ACER3 decreases with age |
ACER3 |
— |
adipose tissue |
Human |
|
DAA3697 |
Gene expression of ACIN1 increases with age |
ACIN1 |
— |
skin |
Human |
|
DAA2973 |
Gene expression of ACLY decreases with age |
ACLY |
— |
skin |
Human |
|
DAA2974 |
Gene expression of ACO1 decreases with age |
ACO1 |
— |
skin |
Human |
|
DAA3676 |
Gene expression of ACOT7 decreases with age |
ACOT7 |
— |
skin |
Human |
|
DAA3713 |
Gene expression of ACSBG1 decreases with age |
ACSBG1 |
— |
skin |
Human |
|
DAA3875 |
Gene expression of ACSL5 decreases with age |
ACSL5 |
— |
skin |
Human |
|
DAA3378 |
Gene expression of ACSM3 decreases with age |
ACSM3 |
— |
skin |
Human |
|
DAA3974 |
Gene expression of ACSS2 decreases with age |
ACSS2 |
— |
skin |
Human |
|
DAA2908 |
Gene expression of ACSS2 decreases with age |
ACSS2 |
— |
adipose tissue |
Human |
|
DAA2975 |
Gene expression of ACTC1 increases with age |
ACTC1 |
— |
skin |
Human |
|
DAA2976 |
Gene expression of ACTG2 increases with age |
ACTG2 |
— |
skin |
Human |
|
DAA4142 |
Gene expression of ACTR5 increases with age |
ACTR5 |
— |
skin |
Human |
|
DAA2977 |
Gene expression of ACVR1B increases with age |
ACVR1B |
— |
skin |
Human |
|
DAA2978 |
Gene expression of ACVR2A increases with age |
ACVR2A |
— |
skin |
Human |
|
DAA2979 |
Gene expression of ACYP1 increases with age |
ACYP1 |
— |
skin |
Human |
|
DAA2779 |
Gene expression of ADA decreases with age |
ADA |
— |
adipose tissue |
Human |
|
DAA2980 |
Gene expression of ADA decreases with age |
ADA |
— |
skin |
Human |
|
DAA4010 |
Gene expression of ADAMTSL3 increases with age |
ADAMTSL3 |
— |
skin |
Human |
|
DAA3965 |
Gene expression of ADAP2 decreases with age |
ADAP2 |
— |
skin |
Human |
|
DAA2981 |
Gene expression of ADARB1 increases with age |
ADARB1 |
— |
skin |
Human |
|
DAA4007 |
Gene expression of ADCK1 decreases with age |
ADCK1 |
— |
skin |
Human |
|
DAA4244 |
Gene expression of ADCK2 decreases with age |
ADCK2 |
— |
skin |
Human |
|
DAA4000 |
Gene expression of ADCK3 increases with age |
ADCK3 |
— |
skin |
Human |
|
DAA4122 |
Gene expression of ADIPOR2 decreases with age |
ADIPOR2 |
— |
skin |
Human |
|
DAA2780 |
Gene expression of ADM increases with age |
ADM |
— |
adipose tissue |
Human |
|
DAA4296 |
Gene expression of AGAP3 increases with age |
AGAP3 |
— |
skin |
Human |
|
DAA3627 |
Gene expression of AGPAT1 decreases with age |
AGPAT1 |
— |
skin |
Human |
|
DAA3991 |
Gene expression of AGPAT3 decreases with age |
AGPAT3 |
— |
skin |
Human |
|
DAA2879 |
Gene expression of AGTPBP1 increases with age |
AGTPBP1 |
— |
adipose tissue |
Human |
|
DAA4003 |
Gene expression of AGTRAP decreases with age |
AGTRAP |
— |
skin |
Human |
|
DAA3719 |
Gene expression of AHCYL2 increases with age |
AHCYL2 |
— |
skin |
Human |
|
DAA3858 |
Gene expression of AHSP decreases with age |
AHSP |
— |
skin |
Human |
|
DAA2983 |
Gene expression of AIF1 decreases with age |
AIF1 |
— |
skin |
Human |
|
DAA3531 |
Gene expression of AIFM1 decreases with age |
AIFM1 |
— |
skin |
Human |
|
DAA4210 |
Gene expression of AJUBA increases with age |
AJUBA |
— |
skin |
Human |
|
DAA3608 |
Gene expression of AKAP8 increases with age |
AKAP8 |
— |
skin |
Human |
|
DAA3496 |
Gene expression of AKR1C3 decreases with age |
AKR1C3 |
— |
skin |
Human |
|
DAA3494 |
Gene expression of AKR7A2 decreases with age |
AKR7A2 |
— |
skin |
Human |
|
DAA2984 |
Gene expression of ALAS1 decreases with age |
ALAS1 |
— |
skin |
Human |
|
DAA2850 |
Gene expression of ALDH1A2 increases with age |
ALDH1A2 |
— |
adipose tissue |
Human |
|
DAA3646 |
Gene expression of ALDH1L1 decreases with age |
ALDH1L1 |
— |
skin |
Human |
|
DAA2985 |
Gene expression of ALDH3B2 decreases with age |
ALDH3B2 |
— |
skin |
Human |
|
DAA3269 |
Gene expression of ALDH6A1 decreases with age |
ALDH6A1 |
— |
skin |
Human |
|
DAA2986 |
Gene expression of ALDOB increases with age |
ALDOB |
— |
skin |
Human |
DAA2989 |
Gene expression of ALOX15B decreases with age |
ALOX15B |
— |
skin |
Human |
|
DAA2988 |
Gene expression of ALOX5AP decreases with age |
ALOX5AP |
— |
skin |
Human |
|
DAA2987 |
Gene expression of ALOX5 increases with age |
ALOX5 |
— |
skin |
Human |
|
DAA4152 |
Gene expression of ALPK1 increases with age |
ALPK1 |
— |
skin |
Human |
|
DAA4408 |
Gene expression of ALS2CL increases with age |
ALS2CL |
— |
skin |
Human |
|
DAA3740 |
Gene expression of AMACR decreases with age |
AMACR |
— |
skin |
Human |
|
DAA2990 |
Gene expression of AMT increases with age |
AMT |
— |
skin |
Human |
|
DAA3866 |
Gene expression of ANAPC11 decreases with age |
ANAPC11 |
— |
skin |
Human |
|
DAA3818 |
Gene expression of ANAPC4 increases with age |
ANAPC4 |
— |
skin |
Human |
|
DAA3864 |
Gene expression of ANAPC5 increases with age |
ANAPC5 |
— |
skin |
Human |
|
DAA4243 |
Gene expression of ANGEL2 increases with age |
ANGEL2 |
— |
skin |
Human |
|
DAA3727 |
Gene expression of ANGPTL2 decreases with age |
ANGPTL2 |
— |
skin |
Human |
|
DAA4362 |
Gene expression of ANKAR increases with age |
ANKAR |
— |
skin |
Human |
|
DAA4054 |
Gene expression of ANKEF1 decreases with age |
ANKEF1 |
— |
skin |
Human |
|
DAA4002 |
Gene expression of ANKMY2 increases with age |
ANKMY2 |
— |
skin |
Human |
|
DAA4038 |
Gene expression of ANKRA2 increases with age |
ANKRA2 |
— |
skin |
Human |
|
DAA4225 |
Gene expression of ANKRD13A increases with age |
ANKRD13A |
— |
skin |
Human |
|
DAA4435 |
Gene expression of ANKRD13D increases with age |
ANKRD13D |
— |
skin |
Human |
|
DAA4351 |
Gene expression of ANKRD35 increases with age |
ANKRD35 |
— |
skin |
Human |
|
DAA3848 |
Gene expression of ANKRD39 decreases with age |
ANKRD39 |
— |
skin |
Human |
|
DAA2880 |
Gene expression of ANKS1A increases with age |
ANKS1A |
— |
adipose tissue |
Human |
|
DAA3927 |
Gene expression of ANKZF1 increases with age |
ANKZF1 |
— |
skin |
Human |
|
DAA3926 |
Gene expression of ANO10 decreases with age |
ANO10 |
— |
skin |
Human |
|
DAA3517 |
Gene expression of AP1G2 increases with age |
AP1G2 |
— |
skin |
Human |
|
DAA3516 |
Gene expression of AP1S2 decreases with age |
AP1S2 |
— |
skin |
Human |
DAA3054 |
Gene expression of AP2S1 decreases with age |
AP2S1 |
— |
skin |
Human |
|
DAA3638 |
Gene expression of AP4B1 increases with age |
AP4B1 |
— |
skin |
Human |
|
DAA3938 |
Gene expression of AP5S1 decreases with age |
AP5S1 |
— |
skin |
Human |
|
DAA2991 |
Gene expression of APAF1 increases with age |
APAF1 |
— |
skin |
Human |
|
DAA3610 |
Gene expression of APBB3 increases with age |
APBB3 |
— |
skin |
Human |
|
DAA2954 |
Gene expression of APCDD1L decreases with age |
APCDD1L |
— |
adipose tissue |
Human |
|
DAA2781 |
Gene expression of APEH decreases with age |
APEH |
— |
adipose tissue |
Human |
|
DAA2992 |
Gene expression of APEH decreases with age |
APEH |
— |
skin |
Human |
|
DAA4176 |
Gene expression of APH1B decreases with age |
APH1B |
— |
skin |
Human |
|
DAA4005 |
Gene expression of APMAP decreases with age |
APMAP |
— |
skin |
Human |
|
DAA4327 |
Gene expression of APOA1BP decreases with age |
APOA1BP |
— |
skin |
Human |
|
DAA2932 |
Gene expression of APOLD1 increases with age |
APOLD1 |
— |
adipose tissue |
Human |
|
DAA2782 |
Gene expression of APRT decreases with age |
APRT |
— |
adipose tissue |
Human |
|
DAA2993 |
Gene expression of APRT decreases with age |
APRT |
— |
skin |
Human |
|
DAA2994 |
Gene expression of ARG2 decreases with age |
ARG2 |
— |
skin |
Human |
|
DAA3921 |
Gene expression of ARGLU1 increases with age |
ARGLU1 |
— |
skin |
Human |
|
DAA3969 |
Gene expression of ARHGAP15 decreases with age |
ARHGAP15 |
— |
skin |
Human |
|
DAA2944 |
Gene expression of ARHGAP33 decreases with age |
ARHGAP33 |
— |
adipose tissue |
Human |
|
DAA4287 |
Gene expression of ARHGAP33 increases with age |
ARHGAP33 |
— |
skin |
Human |
|
DAA3561 |
Gene expression of ARHGEF10 increases with age |
ARHGEF10 |
— |
skin |
Human |
|
DAA4459 |
Gene expression of ARHGEF37 increases with age |
ARHGEF37 |
— |
skin |
Human |
|
DAA3831 |
Gene expression of ARHGEF4 increases with age |
ARHGEF4 |
— |
skin |
Human |
|
DAA3879 |
Gene expression of ARID4B increases with age |
ARID4B |
— |
skin |
Human |
|
DAA2866 |
Gene expression of ARIH2 increases with age |
ARIH2 |
— |
adipose tissue |
Human |
|
DAA3596 |
Gene expression of ARL4A increases with age |
ARL4A |
— |
skin |
Human |
AA2859 |
Gene expression of ARL4A increases with age |
ARL4A |
— |
adipose tissue |
Human |
|
DAA4265 |
Gene expression of ARMC6 decreases with age |
ARMC6 |
— |
skin |
Human |
|
DAA2996 |
Gene expression of ARNTL increases with age |
ARNTL |
— |
skin |
Human |
|
DAA3594 |
Gene expression of ARPC2 increases with age |
ARPC2 |
— |
skin |
Human |
|
DAA4253 |
Gene expression of ARRDC4 increases with age |
ARRDC4 |
— |
skin |
Human |
|
DAA2997 |
Gene expression of ARSF decreases with age |
ARSF |
— |
skin |
Human |
|
DAA3508 |
Gene expression of ASAP2 increases with age |
ASAP2 |
— |
skin |
Human |
|
DAA4132 |
Gene expression of ASB13 decreases with age |
ASB13 |
— |
skin |
Human |
|
DAA2998 |
Gene expression of ASCL2 increases with age |
ASCL2 |
— |
skin |
Human |
|
DAA2972 |
Gene expression of ASIC2 decreases with age |
ASIC2 |
— |
skin |
Human |
|
DAA2999 |
Gene expression of ASNS increases with age |
ASNS |
— |
skin |
Human |
|
DAA4410 |
Gene expression of ASPM increases with age |
ASPM |
— |
skin |
Human |
|
DAA3958 |
Gene expression of ASUN increases with age |
ASUN |
— |
skin |
Human |
|
DAA3692 |
Gene expression of ATF6 decreases with age |
ATF6 |
— |
skin |
Human |
|
DAA2877 |
Gene expression of ATF6 decreases with age |
ATF6 |
— |
adipose tissue |
Human |
|
DAA4228 |
Gene expression of ATG16L2 increases with age |
ATG16L2 |
— |
skin |
Human |
|
DAA2942 |
Gene expression of ATG4A increases with age |
ATG4A |
— |
adipose tissue |
Human |
|
DAA3766 |
Gene expression of ATL3 decreases with age |
ATL3 |
— |
skin |
Human |
|
DAA3000 |
Gene expression of ATOX1 decreases with age |
ATOX1 |
— |
skin |
Human |
|
DAA3001 |
Gene expression of ATP5D decreases with age |
ATP5D |
— |
skin |
Human |
|
DAA3923 |
Gene expression of ATP5SL decreases with age |
ATP5SL |
— |
skin |
Human |
|
DAA2888 |
Gene expression of ATP6V0A4 increases with age |
ATP6V0A4 |
— |
adipose tissue |
Human |
|
DAA3004 |
Gene expression of ATP6V0B decreases with age |
ATP6V0B |
— |
skin |
Human |
|
DAA3002 |
Gene expression of ATP6V0C decreases with age |
ATP6V0C |
— |
skin |
Human |
|
DAA3527 |
Gene expression of ATP6V0D1 decreases with age |
ATP6V0D1 |
— |
skin |
Human |
DAA3520 |
Gene expression of ATP6V0E1 decreases with age |
ATP6V0E1 |
— |
skin |
Human |
|
DAA3003 |
Gene expression of ATP6V1C1 increases with age |
ATP6V1C1 |
— |
skin |
Human |
|
DAA3862 |
Gene expression of ATP6V1D decreases with age |
ATP6V1D |
— |
skin |
Human |
|
DAA4267 |
Gene expression of ATPIF1 increases with age |
ATPIF1 |
— |
skin |
Human |
|
DAA3775 |
Gene expression of AUTS2 increases with age |
AUTS2 |
— |
skin |
Human |
|
DAA4371 |
Gene expression of AWAT1 decreases with age |
AWAT1 |
— |
skin |
Human |
|
DAA4372 |
Gene expression of AWAT2 decreases with age |
AWAT2 |
— |
skin |
Human |
|
DAA4322 |
Gene expression of AXDND1 decreases with age |
AXDND1 |
— |
skin |
Human |
|
DAA3948 |
Gene expression of BATF3 decreases with age |
BATF3 |
— |
skin |
Human |
|
DAA3668 |
Gene expression of BAZ1A increases with age |
BAZ1A |
— |
skin |
Human |
|
DAA3822 |
Gene expression of BAZ2B increases with age |
BAZ2B |
— |
skin |
Human |
|
DAA2844 |
Gene expression of BBOX1 decreases with age |
BBOX1 |
— |
adipose tissue |
Human |
|
DAA3005 |
Gene expression of BBS2 increases with age |
BBS2 |
— |
skin |
Human |
|
DAA3006 |
Gene expression of BBS4 increases with age |
BBS4 |
— |
skin |
Human |
|
DAA4051 |
Gene expression of BCAN decreases with age |
BCAN |
— |
skin |
Human |
|
DAA3978 |
Gene expression of BCAP29 decreases with age |
BCAP29 |
— |
skin |
Human |
|
DAA3906 |
Gene expression of BCAS3 decreases with age |
BCAS3 |
— |
skin |
Human |
|
DAA3007 |
Gene expression of BCAT2 decreases with age |
BCAT2 |
— |
skin |
Human |
|
DAA3008 |
Gene expression of BCKDHB decreases with age |
BCKDHB |
— |
skin |
Human |
|
DAA3609 |
Gene expression of BCKDK decreases with age |
BCKDK |
— |
skin |
Human |
|
DAA3883 |
Gene expression of BCL11A increases with age |
BCL11A |
— |
skin |
Human |
|
DAA2783 |
Gene expression of BCL6 decreases with age |
BCL6 |
— |
adipose tissue |
Human |
|
DAA3009 |
Gene expression of BCL6 increases with age |
BCL6 |
— |
skin |
Human |
|
DAA3010 |
Gene expression of BDH1 decreases with age |
BDH1 |
— |
skin |
Human |
|
DAA3970 |
Gene expression of BEX1 increases with age |
BEX1 |
— |
skin |
Human |
DAA3798 |
Gene expression of BHLHE22 decreases with age |
BHLHE22 |
— |
skin |
Human |
|
DAA2847 |
Gene expression of BHLHE40 decreases with age |
BHLHE40 |
— |
adipose tissue |
Human |
|
DAA3011 |
Gene expression of BID decreases with age |
BID |
— |
skin |
Human |
|
DAA4017 |
Gene expression of BIRC6 increases with age |
BIRC6 |
— |
skin |
Human |
|
DAA3654 |
Gene expression of BLCAP increases with age |
BLCAP |
— |
skin |
Human |
|
DAA2784 |
Gene expression of BMP6 increases with age |
BMP6 |
— |
adipose tissue |
Human |
|
DAA3575 |
Gene expression of BMS1 increases with age |
BMS1 |
— |
skin |
Human |
|
DAA2785 |
Gene expression of BMX increases with age |
BMX |
— |
adipose tissue |
Human |
|
DAA4250 |
Gene expression of BOC increases with age |
BOC |
— |
skin |
Human |
|
DAA3012 |
Gene expression of BOK decreases with age |
BOK |
— |
skin |
Human |
|
DAA3653 |
Gene expression of BRD8 increases with age |
BRD8 |
— |
skin |
Human |
|
DAA3558 |
Gene expression of BRE decreases with age |
BRE |
— |
skin |
Human |
|
DAA4341 |
Gene expression of BRI3BP decreases with age |
BRI3BP |
— |
skin |
Human |
|
DAA3788 |
Gene expression of BSCL2 decreases with age |
BSCL2 |
— |
skin |
Human |
|
DAA3014 |
Gene expression of BSG decreases with age |
BSG |
— |
skin |
Human |
|
DAA2946 |
Gene expression of BTBD11 decreases with age |
BTBD11 |
— |
adipose tissue |
Human |
|
DAA3687 |
Gene expression of BTBD3 increases with age |
BTBD3 |
— |
skin |
Human |
|
DAA4232 |
Gene expression of BTBD6 increases with age |
BTBD6 |
— |
skin |
Human |
|
DAA3015 |
Gene expression of BTD decreases with age |
BTD |
— |
skin |
Human |
|
DAA3666 |
Gene expression of BTN2A1 increases with age |
BTN2A1 |
— |
skin |
Human |
|
DAA3514 |
Gene expression of BUD31 decreases with age |
BUD31 |
— |
skin |
Human |
|
DAA4394 |
Gene expression of C11orf45 increases with age |
C11orf45 |
— |
skin |
Human |
|
DAA4215 |
Gene expression of C11orf70 increases with age |
C11orf70 |
— |
skin |
Human |
|
DAA4298 |
Gene expression of C11orf74 decreases with age |
C11orf74 |
— |
skin |
Human |
|
DAA4248 |
Gene expression of C12orf65 increases with age |
C12orf65 |
— |
skin |
Human |
DAA3998 |
Gene expression of C14orf132 decreases with age |
C14orf132 |
— |
skin |
Human |
|
DAA4303 |
Gene expression of C14orf28 increases with age |
C14orf28 |
— |
skin |
Human |
|
DAA3556 |
Gene expression of C14orf2 decreases with age |
C14orf2 |
— |
skin |
Human |
|
DAA4305 |
Gene expression of C15orf27 increases with age |
C15orf27 |
— |
skin |
Human |
|
DAA4442 |
Gene expression of C15orf38 decreases with age |
ARPIN |
— |
skin |
Human |
|
DAA4452 |
Gene expression of C15orf59 increases with age |
C15orf59 |
— |
skin |
Human |
|
DAA4309 |
Gene expression of C17orf49 decreases with age |
C17orf49 |
— |
skin |
Human |
|
DAA3980 |
Gene expression of C19orf10 decreases with age |
C19orf10 |
— |
skin |
Human |
|
DAA3919 |
Gene expression of C19orf24 decreases with age |
C19orf24 |
— |
skin |
Human |
|
DAA4325 |
Gene expression of C1orf122 decreases with age |
C1orf122 |
— |
skin |
Human |
|
DAA4263 |
Gene expression of C1orf158 decreases with age |
C1orf158 |
— |
skin |
Human |
|
DAA4162 |
Gene expression of C1orf21 increases with age |
C1orf21 |
— |
skin |
Human |
|
DAA4349 |
Gene expression of C1orf51 decreases with age |
CIART |
— |
skin |
Human |
|
DAA4001 |
Gene expression of C1orf63 increases with age |
RSRP1 |
— |
skin |
Human |
|
DAA4355 |
Gene expression of C1orf64 increases with age |
C1orf64 |
— |
skin |
Human |
|
DAA3016 |
Gene expression of C1QA decreases with age |
C1QA |
— |
skin |
Human |
|
DAA3017 |
Gene expression of C1QB decreases with age |
C1QB |
— |
skin |
Human |
|
DAA3018 |
Gene expression of C1QC decreases with age |
C1QC |
— |
skin |
Human |
|
DAA4282 |
Gene expression of C1QTNF1 decreases with age |
C1QTNF1 |
— |
skin |
Human |
|
DAA4283 |
Gene expression of C1QTNF5 decreases with age |
C1QTNF5 |
— |
skin |
Human |
|
DAA4284 |
Gene expression of C1QTNF6 decreases with age |
C1QTNF6 |
— |
skin |
Human |
|
DAA3977 |
Gene expression of C20orf24 decreases with age |
C20orf24 |
— |
skin |
Human |
|
DAA3481 |
Gene expression of C21orf33 decreases with age |
C21orf33 |
— |
skin |
Human |
|
DAA4076 |
Gene expression of C6orf106 decreases with age |
C6orf106 |
— |
skin |
Human |
|
DAA2963 |
Gene expression of C6orf52 increases with age |
C6orf52 |
— |
adipose tissue |
Human |
DAA4138 |
Gene expression of C7orf63 increases with age |
CFAP69 |
— |
skin |
Human |
|
DAA3984 |
Gene expression of C8orf44 increases with age |
C8orf44 |
— |
skin |
Human |
|
DAA4111 |
Gene expression of C9orf16 decreases with age |
C9orf16 |
— |
skin |
Human |
|
DAA2786 |
Gene expression of CA12 decreases with age |
CA12 |
— |
adipose tissue |
Human |
|
DAA3022 |
Gene expression of CA12 increases with age |
CA12 |
— |
skin |
Human |
|
DAA3743 |
Gene expression of CA14 decreases with age |
CA14 |
— |
skin |
Human |
|
DAA3021 |
Gene expression of CA9 increases with age |
CA9 |
— |
skin |
Human |
|
DAA3665 |
Gene expression of CACFD1 decreases with age |
CACFD1 |
— |
skin |
Human |
|
DAA3023 |
Gene expression of CACNA1F increases with age |
CACNA1F |
— |
skin |
Human |
|
DAA2958 |
Gene expression of CADM2 increases with age |
CADM2 |
— |
adipose tissue |
Human |
|
DAA4040 |
Gene expression of CADM3 decreases with age |
CADM3 |
— |
skin |
Human |
|
DAA3025 |
Gene expression of CALD1 increases with age |
CALD1 |
— |
skin |
Human |
|
DAA3026 |
Gene expression of CALML3 decreases with age |
CALML3 |
— |
skin |
Human |
|
DAA4252 |
Gene expression of CALML4 increases with age |
CALML4 |
— |
skin |
Human |
|
DAA3027 |
Gene expression of CALR decreases with age |
CALR |
— |
skin |
Human |
|
DAA3028 |
Gene expression of CALU decreases with age |
CALU |
— |
skin |
Human |
|
DAA3830 |
Gene expression of CALY increases with age |
CALY |
— |
skin |
Human |
|
DAA3029 |
Gene expression of CAMK2G increases with age |
CAMK2G |
— |
skin |
Human |
|
DAA3030 |
Gene expression of CANX decreases with age |
CANX |
— |
skin |
Human |
|
DAA4255 |
Gene expression of CAPN13 decreases with age |
CAPN13 |
— |
skin |
Human |
|
DAA3031 |
Gene expression of CAPNS1 decreases with age |
CAPNS1 |
— |
skin |
Human |
|
DAA4095 |
Gene expression of CAPRIN2 increases with age |
CAPRIN2 |
— |
skin |
Human |
|
DAA2882 |
Gene expression of CARHSP1 decreases with age |
CARHSP1 |
— |
adipose tissue |
Human |
|
DAA3933 |
Gene expression of CASC1 increases with age |
CASC1 |
— |
skin |
Human |
|
DAA3032 |
Gene expression of CASQ2 increases with age |
CASQ2 |
— |
skin |
Human |
DAA4039 |
Gene expression of CATSPERG increases with age |
CATSPERG |
— |
skin |
Human |
|
DAA3731 |
Gene expression of CBX7 increases with age |
CBX7 |
— |
skin |
Human |
|
DAA3034 |
Gene expression of CCBL1 increases with age |
CCBL1 |
— |
skin |
Human |
|
DAA4164 |
Gene expression of CCDC130 increases with age |
CCDC130 |
— |
skin |
Human |
|
DAA4028 |
Gene expression of CCDC146 increases with age |
CCDC146 |
— |
skin |
Human |
|
DAA4075 |
Gene expression of CCDC14 increases with age |
CCDC14 |
— |
skin |
Human |
|
DAA4365 |
Gene expression of CCDC167 decreases with age |
CCDC167 |
— |
skin |
Human |
|
DAA3849 |
Gene expression of CCDC174 increases with age |
CCDC174 |
— |
skin |
Human |
|
DAA2934 |
Gene expression of CCDC3 increases with age |
CCDC3 |
— |
adipose tissue |
Human |
|
DAA4279 |
Gene expression of CCDC85A increases with age |
CCDC85A |
— |
skin |
Human |
|
DAA4109 |
Gene expression of CCDC86 decreases with age |
CCDC86 |
— |
skin |
Human |
|
DAA3384 |
Gene expression of CCL21 decreases with age |
CCL21 |
— |
skin |
Human |
|
DAA3385 |
Gene expression of CCL23 decreases with age |
CCL23 |
— |
skin |
Human |
|
DAA3986 |
Gene expression of CCL28 increases with age |
CCL28 |
— |
skin |
Human |
|
DAA3383 |
Gene expression of CCL2 increases with age |
CCL2 |
— |
skin |
Human |
|
DAA3035 |
Gene expression of CCNF decreases with age |
CCNF |
— |
skin |
Human |
|
DAA3756 |
Gene expression of CCRN4L decreases with age |
CCRN4L |
— |
skin |
Human |
|
DAA3038 |
Gene expression of CD14 decreases with age |
CD14 |
— |
skin |
Human |
|
DAA4415 |
Gene expression of CD163L1 decreases with age |
CD163L1 |
— |
skin |
Human |
|
DAA3036 |
Gene expression of CD1B decreases with age |
CD1B |
— |
skin |
Human |
|
DAA3037 |
Gene expression of CD1C decreases with age |
CD1C |
— |
skin |
Human |
|
DAA3826 |
Gene expression of CD209 decreases with age |
CD209 |
— |
skin |
Human |
|
DAA3615 |
Gene expression of CD2BP2 decreases with age |
CD2BP2 |
— |
skin |
Human |
|
DAA3674 |
Gene expression of CD300A increases with age |
CD300A |
— |
skin |
Human |
|
DAA3040 |
Gene expression of CD79B decreases with age |
CD79B |
— |
skin |
Human |
DAA3041 |
Gene expression of CDA decreases with age |
CDA |
— |
skin |
Human |
|
DAA3511 |
Gene expression of CDC16 increases with age |
CDC16 |
— |
skin |
Human |
|
DAA3042 |
Gene expression of CDC25C increases with age |
CDC25C |
— |
skin |
Human |
|
DAA4081 |
Gene expression of CDCP1 increases with age |
CDCP1 |
— |
skin |
Human |
|
DAA3043 |
Gene expression of CDH12 decreases with age |
CDH12 |
— |
skin |
Human |
|
DAA4254 |
Gene expression of CDHR1 increases with age |
CDHR1 |
— |
skin |
Human |
|
DAA2823 |
Gene expression of CDK14 decreases with age |
CDK14 |
— |
adipose tissue |
Human |
|
DAA3044 |
Gene expression of CDK3 increases with age |
CDK3 |
— |
skin |
Human |
|
DAA4155 |
Gene expression of CDK5RAP3 increases with age |
CDK5RAP3 |
— |
skin |
Human |
|
DAA3522 |
Gene expression of CDKL2 decreases with age |
CDKL2 |
— |
skin |
Human |
|
DAA3045 |
Gene expression of CDKN1A decreases with age |
CDKN1A |
— |
skin |
Human |
|
DAA4360 |
Gene expression of CDPF1 increases with age |
CDPF1 |
— |
skin |
Human |
|
DAA4420 |
Gene expression of CDRT4 increases with age |
CDRT4 |
— |
skin |
Human |
|
DAA3046 |
Gene expression of CEBPA decreases with age |
CEBPA |
— |
skin |
Human |
|
DAA3882 |
Gene expression of CECR1 decreases with age |
CECR1 |
— |
skin |
Human |
|
DAA3968 |
Gene expression of CENPJ increases with age |
CENPJ |
— |
skin |
Human |
|
DAA4104 |
Gene expression of CENPM decreases with age |
CENPM |
— |
skin |
Human |
|
DAA3565 |
Gene expression of CEP135 increases with age |
CEP135 |
— |
skin |
Human |
|
DAA4153 |
Gene expression of CEP63 increases with age |
CEP63 |
— |
skin |
Human |
|
DAA4242 |
Gene expression of CEP95 increases with age |
CEP95 |
— |
skin |
Human |
|
DAA3842 |
Gene expression of CERCAM decreases with age |
CERCAM |
— |
skin |
Human |
|
DAA2890 |
Gene expression of CERCAM decreases with age |
CERCAM |
— |
adipose tissue |
Human |
|
DAA4418 |
Gene expression of CES4A increases with age |
CES4A |
— |
skin |
Human |
|
DAA3047 |
Gene expression of CETN3 increases with age |
CETN3 |
— |
skin |
Human |
|
DAA2846 |
Gene expression of CGGBP1 decreases with age |
CGGBP1 |
— |
adipose tissue |
Human |
DAA4463 |
Gene expression of CHCHD10 decreases with age |
CHCHD10 |
— |
skin |
Human |
|
DAA4194 |
Gene expression of CHCHD5 decreases with age |
CHCHD5 |
— |
skin |
Human |
|
DAA3049 |
Gene expression of CHI3L2 decreases with age |
CHI3L2 |
— |
skin |
Human |
|
DAA3050 |
Gene expression of CHN1 decreases with age |
CHN1 |
— |
skin |
Human |
|
DAA3051 |
Gene expression of CHN2 decreases with age |
CHN2 |
— |
skin |
Human |
|
DAA4120 |
Gene expression of CHPF decreases with age |
CHPF |
— |
skin |
Human |
|
DAA3987 |
Gene expression of CHST7 decreases with age |
CHST7 |
— |
skin |
Human |
|
DAA4432 |
Gene expression of CHSY3 decreases with age |
CHSY3 |
— |
skin |
Human |
|
DAA3542 |
Gene expression of CIAO1 increases with age |
CIAO1 |
— |
skin |
Human |
|
DAA3052 |
Gene expression of CIDEA decreases with age |
CIDEA |
— |
skin |
Human |
|
DAA2788 |
Gene expression of CISH decreases with age |
CISH |
— |
adipose tissue |
Human |
|
DAA3053 |
Gene expression of CISH decreases with age |
CISH |
— |
skin |
Human |
|
DAA2787 |
Gene expression of CKB decreases with age |
CKB |
— |
adipose tissue |
Human |
|
DAA3736 |
Gene expression of CLCF1 decreases with age |
CLCF1 |
— |
skin |
Human |
|
DAA2837 |
Gene expression of CLDN5 increases with age |
CLDN5 |
— |
adipose tissue |
Human |
|
DAA2867 |
Gene expression of CLEC10A decreases with age |
CLEC10A |
— |
adipose tissue |
Human |
|
DAA3618 |
Gene expression of CLEC10A decreases with age |
CLEC10A |
— |
skin |
Human |
|
DAA3055 |
Gene expression of CLK2 increases with age |
CLK2 |
— |
skin |
Human |
|
DAA4016 |
Gene expression of CLK4 increases with age |
CLK4 |
— |
skin |
Human |
|
DAA4137 |
Gene expression of CLMP decreases with age |
CLMP |
— |
skin |
Human |
|
DAA4460 |
Gene expression of CLPSL2 decreases with age |
CLPSL2 |
— |
skin |
Human |
|
DAA3682 |
Gene expression of CLSTN1 increases with age |
CLSTN1 |
— |
skin |
Human |
|
DAA3569 |
Gene expression of CLSTN3 decreases with age |
CLSTN3 |
— |
skin |
Human |
|
DAA3057 |
Gene expression of CLTA decreases with age |
CLTA |
— |
skin |
Human |
|
DAA4195 |
Gene expression of CMSS1 increases with age |
CMSS1 |
— |
skin |
Human
|
DAA4306 |
Gene expression of CMTM3 decreases with age |
CMTM3 |
— |
skin |
Human |
|
DAA3959 |
Gene expression of CNDP2 decreases with age |
CNDP2 |
— |
skin |
Human |
|
DAA4363 |
Gene expression of CNKSR3 decreases with age |
CNKSR3 |
— |
skin |
Human |
|
DAA3059 |
Gene expression of CNN1 increases with age |
CNN1 |
— |
skin |
Human |
|
DAA3805 |
Gene expression of COA3 decreases with age |
COA3 |
— |
skin |
Human |
|
DAA4471 |
Gene expression of COA5 increases with age |
COA5 |
— |
skin |
Human |
|
DAA3067 |
Gene expression of COL11A1 decreases with age |
COL11A1 |
— |
skin |
Human |
|
DAA3456 |
Gene expression of COL14A1 decreases with age |
COL14A1 |
— |
skin |
Human |
|
DAA3068 |
Gene expression of COL16A1 increases with age |
COL16A1 |
— |
skin |
Human |
|
DAA3069 |
Gene expression of COL17A1 increases with age |
COL17A1 |
— |
skin |
Human |
|
DAA2789 |
Gene expression of COL1A1 decreases with age |
COL1A1 |
— |
adipose tissue |
Human |
|
DAA3060 |
Gene expression of COL1A1 decreases with age |
COL1A1 |
— |
skin |
Human |
|
DAA2790 |
Gene expression of COL1A2 decreases with age |
COL1A2 |
— |
adipose tissue |
Human |
|
DAA3061 |
Gene expression of COL1A2 decreases with age |
COL1A2 |
— |
skin |
Human |
|
DAA3062 |
Gene expression of COL3A1 decreases with age |
COL3A1 |
— |
skin |
Human |
|
DAA2791 |
Gene expression of COL4A2 decreases with age |
COL4A2 |
— |
adipose tissue |
Human |
|
DAA3063 |
Gene expression of COL4A5 increases with age |
COL4A5 |
— |
skin |
Human |
|
DAA3064 |
Gene expression of COL4A6 increases with age |
COL4A6 |
— |
skin |
Human |
|
DAA2792 |
Gene expression of COL5A1 decreases with age |
COL5A1 |
— |
adipose tissue |
Human |
|
DAA3065 |
Gene expression of COL5A2 decreases with age |
COL5A2 |
— |
skin |
Human |
|
DAA3066 |
Gene expression of COL7A1 increases with age |
COL7A1 |
— |
skin |
Human |
|
DAA3485 |
Gene expression of COLQ increases with age |
COLQ |
— |
skin |
Human |
|
DAA4361 |
Gene expression of COMMD1 decreases with age |
COMMD1 |
— |
skin |
Human |
|
DAA4356 |
Gene expression of COMMD7 decreases with age |
COMMD7 |
— |
skin |
Human |
|
DAA3070 |
Gene expression of COMT decreases with age |
COMT |
— |
skin |
Human |